What Is Mounjaro (Tirzepatide) Used For?
Mounjaro® is an FDA-approved medication used to treat type 2 diabetes. It is a dual GLP-1/GIP* receptor agonist which acts to stimulate the release of insulin by the pancreas which lowers blood sugar levels. It can also improve insulin sensitivity and promote weight loss. At this time, Mounjaro is not FDA-approved for weight loss, but it is anticipated to be FDA-approved for this indication in the near future. A study published in the New England Journal of Medicine found in combination with healthy nutrition and increased physical activity, people taking the highest dose of Mounjaro lost on average 21% of their starting body weight after 72 weeks on the medication. Additionally, over 80% of people on the highest dose were able to lose at least 10% of their total body weight. Doctors may prescribe Mounjaro to patients without diabetes ( considered off-label use) for the purpose of weight loss in combination with healthy nutrition and increased physical activity so long as it is medically appropriate.
*glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP)
Learn more about Mounjaro at FORM.
Mounjaro® and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates.
Lauren Lemieux, MD
FACP, ABOM diplomate
Dr. Lauren Lemieux completed her Internal Medicine residency and fellowship in Clinical Nutrition at UCLA. She is board certified in Internal Medicine and diplomate of the American Board of Obesity Medicine, and as a Physician Nutrition Specialist. She is also a fellow of the American College of Physicians. Dr. Lemieux is passionate about helping her patients reach their health goals using personalized nutrition, lifestyle and weight management strategies.
